Vico Therapeutics Announces $60 million (€54 million) Series B Financing to Advance VO659 Clinical-Stage Program for Rare Neurological Diseases and Expand Pipeline
HQ: NL
Founded: 2019
Series B
Sector: Health Care
Investment Raised: EUR 54M €
Valuation Remains Undisclosed
Investors: Ackermans & van Haaren Droia Ventures EQT life science Eurazeo Kurma Partners Polaris Partners Pureos Bioventures
CMR Surgical raises $165m from existing investors SoftBank and Tencent
HQ: UK
Founded: 2014
Series D
Sector: Health Care
Investment Raised: USD 165m €
Valuation Remains Undisclosed
Investors: Ally Bridge Group (https://ally-bridge.com/) Cambridge Innovation Capital (https://www.cic.vc/) Escala Capital (https://escalacapital.com/) LGT group (https://www.lgt.com/) Lightrock (https://www.lightrock.com/) RPMI Railpen (https://www.railpen.com/) SoftBank Vision Fund (https://visionfund.com/) Tencent (https://www.tencent.com/en-us/) Watrium AS (https://watrium.no/)
Investors: August Capital (https://www.augustcap.com/) Rally Ventures (https://www.rallyventures.com/) Vista Equity Partners (https://www.vistaequitypartners.com/)